Potential role for statins in the treatment of chronic HCV infection

被引：4
|
作者：
Zhu, Qianqian [1 ]
Han, Qunying [1 ]
Liu, Zhengwen [1 ]
机构：
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Infect Dis, Xian 710061, Shaanxi Provinc, Peoples R China
来源：
FUTURE VIROLOGY | 2013年 / 8卷 / 08期
关键词：
chronic hepatitis C; direct-acting antiviral; host-targeting agent; IFN-; ribavirin; statin; treatment; CHRONIC HEPATITIS-C; VIRUS-RNA REPLICATION; PEGYLATED INTERFERON; COMBINATION THERAPY; ANTIVIRAL EFFICACY; PLUS RIBAVIRIN; GENOTYPE; 1B; OPEN-LABEL; FLUVASTATIN; RESISTANCE;
D O I：
10.2217/fvl.13.70
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：727 / 729
页数：3
相关论文
共 50 条
  • [31] The impact of antihyperlipidemic drugs on the viral load of patients with chronic hepatitis C infection: a meta-analysis
    Grammatikos, G.
    Farnik, H.
    Bon, D.
    Boehlig, A.
    Bader, T.
    Berg, T.
    Zeuzem, S.
    Herrmann, E.
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 (08) : 533 - 541
  • [32] Personality disorders do not affect treatment outcomes for chronic HCV infection in Spanish prisoners: the Perseo study
    Marco, Andres
    Anton, Jose J.
    Trujols, Joan
    de la Hoya, Pablo Saiz
    de Juan, Jose
    Faraco, Inmaculada
    Cayla, Joan A.
    BMC INFECTIOUS DISEASES, 2015, 15
  • [33] Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C
    Loggi, Elisabetta
    Cursaro, Carmela
    Scuteri, Alessandra
    Grandini, Elena
    Panno, Arianna Martello
    Galli, Silvia
    Furlini, Giuliano
    Bernardi, Mauro
    Galli, Claudio
    Andreone, Pietro
    JOURNAL OF CLINICAL VIROLOGY, 2013, 56 (03) : 207 - 211
  • [34] Increased mortality in chronic HCV infection
    Ridruejo, Ezequiel
    ANNALS OF HEPATOLOGY, 2012, 11 (06) : 967 - 968
  • [35] Treatment of HCV infection in liver transplant recipients with ledipasvir and sofosbuvir without ribavirin
    Pillai, A. A.
    Maheshwari, R.
    Vora, R.
    Norvell, J. P.
    Ford, R.
    Parekh, S.
    Cheng, N.
    Patel, A.
    Young, N.
    Spivey, J. R.
    Mgbemena, O.
    Wedd, J. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (11) : 1427 - 1432
  • [36] Combination of Vaniprevir With Peginterferon and Ribavirin Significantly Increases the Rate of SVR in Treatment-Experienced Patients With Chronic HCV Genotype 1 Infection and Cirrhosis
    Rodriguez-Torres, Maribel
    Stoehr, Albrecht
    Gane, Edward J.
    Serfaty, Lawrence
    Lawitz, Eric
    Zhou, Amy
    Bourque, Michael
    Bhanja, Sanhita
    Strizki, Julie
    Barnard, Richard J. O.
    Hwang, Peggy M. T.
    DiNubile, Mark J.
    Mobashery, Niloufar
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (06) : 1029 - +
  • [37] Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
    McHutchison, John G.
    Everson, Gregory T.
    Gordon, Stuart C.
    Jacobson, Ira M.
    Sulkowski, Mark
    Kauffman, Robert
    McNair, Lindsay
    Alam, John
    Muir, Andrew J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (18) : 1827 - 1838
  • [38] A comparative study of variants of pegylated interferon alpha in treatment of chronic HCV patients
    El Sabaawy, Dalia
    El-Haggar, Sahar
    El-Bahrawy, Hoda
    Waked, Imam
    El-Said, Hala
    APMIS, 2015, 123 (06) : 482 - 489
  • [39] Pre-treatment Predictors of Response for Assessing Outcomes to Standard Treatment in Infection with HCV Genotype 3
    Qureshi, Saleem
    Batool, Uzma
    Iqbal, Mussarat
    Burki, Umar Farooq
    Khan, Naqeeb Ullah
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2011, 21 (02): : 64 - 68
  • [40] Insulin Resistance as a Predictor of Early Virologic Response to HCV Therapy Among Chronic HCV Egyptian Patients
    Abd El-Wahab, Ekram W.
    Mikheal, Ashraf
    Sidkey, Fathallah
    Shatat, Hanan Z.
    JOURNAL OF MEDICAL VIROLOGY, 2015, 87 (03) : 428 - 440
12345